In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus. Lantus cost $292 for a 30-day supply. Drugmaker Viatris launched two ...

LONDON – BP is eliminating 4,700 positions, about 5 per cent of its workforce, and more than 3,000 contractor jobs, chief executive Murray Auchincloss told staff on Jan 16 as the London-based ...

BP Plc is eliminating 4,700 positions internally, about 5% of its workforce, and more than 3,000 contractor jobs, Chief Executive Officer Murray Auchincloss told staff on Thursday, as the London-based ...

BP announced on Thursday that it will cut around 4,700 staff, or over 5 per cent of its total workforce, as part of CEO Murray Auchincloss' efforts to reduce costs. BP told staff that 3,000 contractor ...

US Representative Jake Auchincloss of Massachusetts is a member of the House Energy and Commerce Committee.

BP Plc is eliminating 4 700 positions internally, about 5% of its workforce, and more than 3 000 contractor jobs, Chief Executive Officer Murray Auchincloss told staff on Thursday, as the London ...

The company also said 3,000 contractor positions would be cut too. However, in an email to staff, BP CEO Murray Auchincloss said around 2,600 of those contractors "had left the business already." ...

(Bloomberg) -- BP Plc is eliminating 4,700 positions internally, about 5% of its workforce, and more than 3,000 contractor jobs, Chief Executive Officer Murray Auchincloss told staff on Thursday, as ...

BP shares rose 1.4% to 428.8 pence on Thursday in London trading. BP’s fall in recent years reflects strategic miscalculations that extend far beyond Auchincloss’s single year as permanent CEO ...

U.S. Rep. Jake Auchincloss joins WBUR's Morning Edition to express concern that American officials will not enforce a law he co-sponsored requiring the Chinese-owned app TikTok to be sold to a U.S ...

BP is cutting 4,700 jobs, or just over 5 per cent of its workforce, as chief executive Murray Auchincloss tries to save costs and revive a share price that has lagged behind rivals over the past year.